ArticleNaunyn-Schmiedeberg's archives of pharmacology2003

The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.

Antti Haapalinna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.